Toronto Dominion Bank
AZN icon

Toronto Dominion Bank’s AstraZeneca AZN Stock Holding History

Toronto Dominion Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23,450
Closed -$1.9M – 1459
2019
Q1 		$1.9M Buy
+23,450
New +$1.85M ﹤0.01% 838

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Toronto Dominion Bank's AZN Position: Q1 2026 in Review

Toronto Dominion Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 10,353 shares — an estimated $1.9M sold.

Toronto Dominion Bank first reported a position in AZN in Q2 2013 and held it in 50 quarters. The position peaked at $3.81M in Q2 2025. 1,381 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Toronto Dominion Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 10,353 AstraZeneca shares in Q1 2026, an estimated $1.9M.
  • Toronto Dominion Bank first reported a position in AstraZeneca in Q2 2013 and held it in 50 quarters.
  • Toronto Dominion Bank's AstraZeneca position peaked at $3.81M in Q2 2025.
  • 1,381 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.